费森尤斯Fresenius（FMS）2024年年度报告「NYSE」（英文版）（417页）.pdf

1、ANNUAL REPORT 2024Group in figures Table of contentsMedia HubTargets,results,and outlookFresenius is a global healthcare company.Committed to life the health and well-being of patients is Fresenius top priority.For more than 100 years,we have been combining cutting-edge technology with a focus on pa

2、tients,paving the way for the therapies of the future.We save and improve lives and health.We provide access to affordable and innovative medical products and clinical care of the high-est quality.Operating CompaniesFront page2Fresenius|Annual Report 2024Group in figures Table of contentsMedia HubTa

3、rgets,results,and outlook in millions20242023202220212020 Revenue and earningsRevenue 121,52620,307 21,532 19,969 18,476 EBITDA 1,23,6143,319 3,315 3,353 3,042 EBIT 1,22,4892,266 2,190 2,337 2,113 Net income 1,2,31,7491,543 1,729 1,8671,796Depreciation and amortization 1,21,1251,145 1,125 1,016 929

4、Earnings per share in 1,2,33.112.743.083.353.22Cash flow and balance sheetOperating cash flow 12,4472,131 2,031 2,589 2,316 Free cash flow before acquisitions,dividends and lease liabilities 11,6231,1309421,401986Free cash flow after acquisitions,dividends and lease liabilities 11,730188-31838818Cas

5、h conversion rate 11.01.00.90.90.8Total assets43,55045,284 76,400 71,962 66,646 Non-current assets32,10432,764 58,121 54,501 50,874 Equity 420,29019,651 32,218 29,288 26,023 Equity ratio 447%43%42%41%39%Net debt 111,29513,268 13,316 12,650 13,021 Net debt/EBITDA 1,2,53.03.8 3.8 3.6 4.1 Investments 1

6、,61,0351,346 2,015 1,635 1,841 ProfitabilityEBIT margin 1,211.6%11.2%10.2%11.7%11.4%Return on invested capital(ROIC)1,26.2%5.2%5.6%6.2%5.9%Dividend per share in 1.00 70.920.920.88Employees(December 31)1176,486193,865 188,876 185,827 178,140 1 Prior-year figures have been adjusted due to divestments